Trade Pfizer ^PFE

Pfizer (NYSE:PFE) Trading 4.1% Higher on Earnings Beat

Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss

Pfizer (NYSE:PFE) Receives "Neutral" Rating from Cantor Fitzgerald

Pfizer Announces 2025 Grant Recipients Driving Innovative Solutions in Cancer Care

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript

Pfizer (NYSE:PFE) Releases FY 2026 Earnings Guidance

Pfizer uses 'Any Given Sunday' speech in World Cancer Day ad - Ad Age

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Avidity Biosciences (RNA) | Markets Insider

Atlantic Union Bankshares Corp Purchases 32,645 Shares of Pfizer Inc. $PFE - Daily Political

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Pfizer (PFE) | Markets Insider

Pfizer (NYSE:PFE) Trading Down 3.3% - Here's What Happened

Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Pfizer CEO addresses growing competition in weight-loss drugs | Fox Business Video

Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily

Pfizer's stock fell after mixed response to weight-loss data for drug set to compete with Lilly's Zepbound | Morningstar

Pfizer Earnings: Seagen Impairment and Metsera Tolerability Data Incrementally Negative | Morningstar

Pfizer's Diversified Portfolio Supports a Narrow Moat Despite an Upcoming Patent Cliff | Morningstar

Pfizer is at 'the end of the beginning' in entry to GLP-1s: CEO

Pfizer reports quarterly loss, affirms 2026 targets

Pfizer (NYSE:PFE) Shares Gap Down - What's Next?

Pfizer shares slump 3.60% on fourth quarter loss, lower 2026 outlook

Why Pfizer shares are under pressure despite a Q4 earnings beat

Pfizer Projects Revenue Dip in 2026 as Patent Losses Weigh

Pfizer's stock falls after mixed response to weight-loss data for drug set to compete with Lilly's Zepbound | Morningstar

Pfizer's Metsera GLP-1 hits mark for once-monthly dosing | BioWorld

Pfizer (NYSE:PFE) Announces Earnings Results, Beats Estimates By $0.10 EPS

Pfizer study finds patients lose up to 12% of their weight after taking once-a-month drug | Morningstar

Pfizer beats sales estimates on demand for older drugs

Jim Cramer Expresses Concern About Pfizer Despite Its "Terrific Yield"

Jim Cramer on PepsiCo's Recent Rally: "Maybe Something's Going On" - Insider Monkey

Stocks making the biggest moves premarket: PLTR, MRK, PFE

Pfizer's monthly obesity injection drove shows promise in trial

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer (PFE) earnings Q4 2025

AGF Management Ltd. Lowers Position in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Heritage Investors Management Corp

Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure

Principal Financial Group Inc. Reduces Holdings in Pfizer Inc. $PFE

Pfizer beats Q4 projections

Pfizer (NYSE:PFE) Announces Earnings Results, Beats Expectations By $0.10 EPS - Daily Political

Pfizer (NYSE:PFE) Announces Earnings Results - Daily Political

Pfizer Q4 25 Earnings Conference Call At 10:00 AM ET

Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis

Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer

Pfizer News | Markets Insider

Pfizer Reshapes Portfolio With Metsera Deal Novavax Pact And R&D Push - Simply Wall St News

Is Pfizer (PFE) a Good Stock to Buy before Earnings? | Markets Insider

Health Care Up Ahead of Earnings - Health Care Roundup | Morningstar

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Option Volatility And Earnings Report For February 2 - 6

Pfizer Inc. $PFE Stock Position Lifted by Money Concepts Capital Corp

Earnings To Watch: Pfizer (PFE) Reports Q4 Results Tomorrow

Pfizer Inc. $PFE Stake Lifted by Allied Investment Advisors LLC - Daily Political

Pfizer Reshapes Portfolio With Obesity Bet, Vaccine Deal And Pricing Shift

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

AlphaQuest LLC Boosts Stake in Pfizer Inc. $PFE

AlphaQuest LLC Boosts Holdings in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Keybank National Association OH

Gentex Corporation (NASDAQ:GNTX) Q4 2025 Earnings Call Transcript

Lingohr Asset Management GmbH Makes New $589,000 Investment in Pfizer Inc. $PFE - Markets Daily

National Pension Service Acquires 441,539 Shares of Pfizer Inc. $PFE - Markets Daily

Centric Wealth Management Sells 90,514 Shares of Pfizer Inc. $PFE

Frank Rimerman Advisors LLC Raises Stock Position in Pfizer Inc. $PFE

Private Wealth Partners LLC Boosts Holdings in Pfizer Inc. $PFE - Stock Observer

National Pension Service Purchases 441,539 Shares of Pfizer Inc. $PFE - Stock Observer

Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts

Impact Partnership Wealth LLC Buys New Stake in Pfizer Inc. $PFE - Daily Political

Pfizer (NYSE:PFE) Trading 1.2% Higher - Here's What Happened

Cypress Capital Group Boosts Stock Holdings in Pfizer Inc. $PFE

TD Waterhouse Canada Inc. Increases Stock Holdings in Pfizer Inc. $PFE - Stock Observer

Madrigal Weighs Pfizer MASH License And Insider Selling In Growth Plan

Cancer cachexia in STK11/LKB1 -mutated non-small cell lung cancer is dependent on tumor-secreted GDF15

Pfizer Inc. $PFE Shares Sold by New York State Common Retirement Fund

Coastal Bridge Advisors LLC Cuts Stock Holdings in Pfizer Inc. $PFE

AustralianSuper Pty Ltd Boosts Stock Position in Pfizer Inc. $PFE

AE Wealth Management LLC Boosts Holdings in Pfizer Inc. $PFE

Pfizer Inks $530M Deal for Novavax Matrix-M Adjuvant Technology to Boost Vaccine Pipeline

Ruffer LLP Acquires 623,552 Shares of Pfizer Inc. $PFE - Daily Political

Is There Now An Opportunity In Pfizer (PFE) After Recent Pandemic Demand Reset?

This Could Be 1 of the Best Pharmaceutical Stock-Buying Opportunities I've Seen in Years

Hemophilia B Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Novo Nordisk, Sanofi, Pfizer, Belief BioMed, Centessa Pharmaceuticals

Pfizer (NYSE:PFE) Trading Down 2.3% - Here's What Happened - Markets Daily

Pfizer (NYSE:PFE) Shares Down 2.3% - Here's Why

Pfizer Inc. $PFE Shares Acquired by Phoenix Financial Ltd.

OneAscent Financial Services LLC Has $371,000 Stock Holdings in Pfizer Inc. $PFE - Stock Observer

Indoco Remedies Share Price Today Down 4%

RPG LIFE SCIENCES Share Price Today Down 9%

Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial

Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

Fed Independence on the Line? Political Influence in 2026

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

US Economic Outlook 2026: A Roubini Analysis

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Trading wisdom: how can I improve myself as a trader?

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

EQV stock price today: Is EQV Ventures a good investment?

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

TSLQ ETF price forecast: How to track TSLQ ETF prices?

India's Silver Demand Surge: New Loan Framework Boosts Market

ADP Employment Data and the Fed's Policy Path: A Closer Look

Silver and Gold Market Analysis: A Look at the Post-Rally Correction

Starmer Defends Budget Amidst Misleading Claims: 'UK Back on Track'

UBS Analysis: Swiss National Bank Likely Didn't Intervene in FX Market in October

CME Outage Disrupts Global Markets, Sparks Trader Frustration

Gold & Silver Outlook: Fed Rate Cut Expectations & Uncertainty Loom

US-Russia-Ukraine Peace Plan: Deadlock Amidst Western Discord